Miami CEO
MARCH 11 - 13, 2026
The Ritz-Carlton, Key Biscayne, Miami
Miami CEO is hosted annually at The Ritz-Carlton Key Biscayne and convenes biopharma CEOs, investors, and researchers for unique networking opportunities and off-the-record discussion with leaders in the industry.
To request an invitation, email susan@longwoodfund.com.
2025 Participants:
Policy & Research Leaders
Pharma Leaders
Biotech CEOs
Investors
Miami CEO is hosted at The Ritz-Carlton Key Biscayne, Miami.
The Ritz-Carlton Key Biscayne, Miami
455 Grand Bay Drive
Miami, Florida, 33149
The Ritz-Carlton Key Biscayne, Miami is located approximately 30 minutes from Miami International Airport.
Venue
Agenda
Wednesday, April 9, 2025
6:30 - 9:30 pm
WELCOME RECEPTION
Thursday, April 10, 2025
7:00 am
NETWORKING BREAKFAST
7:30 am
WELCOME & OPENING REMARKS
Christoph Westphal, General Partner, Longwood Fund
8:00 AM
BIOPHARMA PIPELINE SOURCING
Bill Mezzanotte, Global Head, R&D, CSL
Frank Nestle, CEO, Deerfield Discovery and Development
Greg Verdine, Co-Founder & Executive Chair, VidaVinci
Moderator: Jenna Foger, SVP, Co-Lead, Life Science, Alexandria Real Estate Equities/Alexandria Venture Investments
8:30 am
ENSURING A PATIENT-DRIVEN FOCUS
Jeff Aronin, Chair & CEO, Paragon Biosciences
Bill Dahut, CSO, American Cancer Society
Lisa Wittmer, Chief Development Officer, Uniquity
Moderator: Vikram Karnani, CEO, Collegium Pharmaceutical
9:00 am
DEAL-MAKING OUTLOOK
Alan Ginsberg, Head, Global Licensing & BD, New Therapeutic Areas, EMD Serono
Daphne Karydas, President & CFO, Flare Therapeutics
Rachel Mears, Partner, Jeito Capital
Krishnan Viswanadhan, Chief Corporate Development and Strategy Officer, Agios
Moderator: John Lepore, CEO, ProFound Therapeutics
9:30 am
ENSURING GLOBAL ACCESS TO TECHNOLOGY
Keting Chu, CEO, Bluejay Therapeutics
Julie Gerberding, CEO, Foundation for the NIH
Debra Miller, CEO, CureDuchenne Ventures
Moderator: Vikas Goyal, Venture Partner, Longwood Fund
10:00 am
INNOVATION IN CLINICAL TRIAL DESIGN
Roy de Souza, CEO, BreakBio
Gavin MacBeath, CEO, TScan Therapeutics
Vikram Sudarsan, CEO, Engrail Therapeutics
Amanda Wagner, CEO, Immunitas
Moderator: Peyton Howell, CEO, Parexel
10:30 am
FIRESIDE CHAT
Levi Garraway, CMO, Genentech Roche
Brent Saunders, CEO, Bausch + Lomb
Moderator: Christoph Westphal, General Partner, Longwood Fund
11:30 am – 2:30 pm
LUNCHEON ON THE BEACH
5:30 - 10:00 pm
SUNSET COCKTAILS & DINNER KEY BISCAYNE YACHT CLUB
Friday, April 11, 2025
7:00 am
NETWORKING BREAKFAST
7:30 am
R&D COLLABORATION
Brant Binder, President, Bonito Biosciences
Trevor Martin, CEO, Mammoth Biosciences
Luis Peña, CEO, Evommune
Hank Safferstein, CEO, Generian
Moderator: Zhen Su, CEO, Marengo Therapeutics
8:00 am
UNITING AS AN INDUSTRY TO ENSURE BIOMEDICAL ACCESS
Meg Alexander, President & COO, Ovid Therapeutics
Brian McVeigh, CEO, Code Therapeutics
Pam Stetkiewicz, COO, Arbor Bio
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: Lizzie Ngo, Principal, Longwood Fund
8:30 am
MANAGING THROUGH UNCERTAINTY
David Donabedian, Executive Partner, Longwood Fund; Founding CEO, Newleos Therapeutics
Michael McCully, CEO, Gate Neurosciences
Victoria Richon, CEO, Entact Bio
Brendan Smith, CEO, Doppler Bio
Moderator: Kendalle Burlin O’Connell, CEO, MassBio
9:00 am
ACCELERATING DRUG DEVELOPMENT
Mat Pletcher, CSO, Weaver
Lara Sullivan, CEO, Pyxis Oncology
Alexis Wallace, CEO, Thrombolytic Science
Sam Waksal, CEO, Graviton Bio
Moderator: Luigi Gentile, Chief Commercial Officer, Rancho Biosciences
9:30 am
REGULATORY & INDUSTRY ROUNDTABLE
John Crowley, CEO, BIO
Peter Marks, former Director, CBER, FDA
Co-Moderators: Jeremy Levin, CEO, Ovid Therapeutics
Christoph Westphal, General Partner, Longwood Fund
10:00 am
PIVOTING THE PIPELINE
Rachel Humphrey, CEO, Normunity
Andrew Miller, Founder & Head, R&D, Karuna Therapeutics
Paul Peter Tak, CEO, Candel Therapeutics
Moderator: Jeremy Levin, CEO, Ovid Therapeutics
10:30 am
INVESTMENT OUTLOOK
Michael Ehlers, Entrepreneur Partner, MPM BioImpact
Benj Garrett, Managing Director, Stifel
Lori Hu, Managing Director, Vertex Ventures
Claudine Prowse, Venture Partner, JP Morgan Asset Management
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
11:00 am
MIMOSA SEND-OFF
